Jinwon Life Sciences has ranked among the top searched stocks for 15 days in the past month.


As of 2:30 PM on the 2nd, Jinwon Life Sciences is trading at 26,800 KRW, up 1.71% from the previous day. This represents a 6.77% increase compared to November 25. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Over the past five days, individual investors have net purchased 71,741 shares, while foreigners and institutions have net sold 46,924 shares and 191 shares, respectively.


On November 30, Jinwon Life Sciences became a market issue with the headline "COVID-19 Treatment Receives FDA Phase 2 Clinical Trial Approval, Surge in Stock Price."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing